Thermo and Sartorius sign disposables agreement

By staff reporter

- Last updated on GMT

Related tags: Sartorius, Thermo fisher scientific, Thermo electron

Thermo Fisher Scientific and Sartorius have signed a supply
agreement continuing the relationship between Sartorius and
Thermo's recently acquired TC Tech.

The agreement stipulates that TC Tech will supply Sartorius with disposable process containers for the biopharmaceutical industry up to the end of 2007 and with disposable process containers fitted with Sartorius filter capsules up to 2012. In return, Sartorius will continue to supply TC Tech with those filter units for a further five years. TC Tech and Sartorius have been business partners supplying disposables to the biopharmaceutical industry for several years. "The main target of this agreement is to optimally satisfy customer needs and to enable a continued product supply for their validated process applications,"​ said Reinhard Vogt, senior vice president of Sales and Marketing of the Biotechnology Division at Sartorius. However, recent merger and acquisition activities had threatened to disrupt the agreement. Fisher Scientific acquired TC Tech for an undisclosed amount in March 2006, before its merger with Thermo Electron later that year. Sartorius is currently in the process of purchasing a controlling stake in one of TC Tech's major competitors - disposables manufacturer, Stedim Biosystems. Sartorius is currently building its biotechnology division, which generated sales revenues of €271m in 2006, and will form combine its current biotechnology division with Stedim to form a new company - Sartorius Stedim Biotech S.A.

Related news

Show more

Related products

show more

A Culture of Innovation as a Differentiation

A Culture of Innovation as a Differentiation

Softigel by Procaps | 06-Dec-2021 | Product Presentation

We create safe, effective and differentiated pharmaceutical solutions and this has been our goal since day 1. The main driver of our growth is innovation...

Strategies to Achieve Successful Approval & Launch

Strategies to Achieve Successful Approval & Launch

Catalent Pharma Solutions | 03-Sep-2020 | Data Sheet

There are several key considerations to how companies should approach commercial-scale manufacturing that may aid the success of their biologic’s launch...

Related suppliers

Follow us

Products

View more

Webinars